RBC-coupled tPA Prevents Whereas tPA Aggravates JNK MAPK-Mediated Impairment of ATP- and Ca-Sensitive K Channel-Mediated Cerebrovasodilation After Cerebral Photothrombosis

Translational Stroke Research

Volumn 3, Issue 1, 2012, Pages 114-121

  Armstead, William M ^a   Ganguly, Kumkum ^b   Riley, John ^a   Zaitsev, Sergei ^a   Cines, Douglas B ^a   Higazi, Abd Al Roof ^a,c   Muzykantov, Vladimir R ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cerebral circulation; Ischemia; Newborn; Plasminogen activators; Signal transduction

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCIUM SENSITIVE POTASSIUM CHANNEL; CROMAKALIM; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; STRESS ACTIVATED PROTEIN KINASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN ARTERY; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROCYTE; HEMODYNAMICS; NEWBORN; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VASODILATATION;

EID: 84857650911     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-011-0105-1     Document Type: Article

References (34)

1. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004; 3: 150-8.
2. Gunther G, Junker R, Strater R, Schobess R, Kurnik K, Kosch A, et al. Symptomatic ischemic stroke in full-term neonates. Stroke. 2000; 31: 2437-41.
3. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol. 1999; 30: 759-69.
4. DeVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001; 345: 417-23.
5. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol. 1998; 5: 135-51.
6. Armstead WM, Riley J, Kiessling JW, Cines DB, Higazi AAR. Novel plasminogen activator inhibitor-1 derived peptide protects against impairment of cerebrovasodilation after photo-thrombosis through inhibition of JNK MAPK. Am J Physiol. 2010; 299: R480-5.
7. Armstead WM, Ganguly K, Riley J, Kiessling JW, Cines DB, Higazi AAR, Zaitsev S, Muzykantov VR. RBC-coupled tPA prevents impairment of cerebral vasodilatory responses through inhibition of JNK and potentiation of p38 MAPK after cerebral photothrombosis in the newborn pig. Ped Crit Care Med 2011; in press. PMID: 21037505.
8. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998; 78: 53-97.
9. + channel function in piglet cerebral arteries. Stroke. 1997; 28: 2273-80.
10. Bari F, Louis T, Meng W, Busija DW. Global ischemia impairs ATP-sensitive K channel function in cerebral arterioles in piglets. Stroke. 1996; 27: 1874-81.
11. Armstead WM. Hypotension dilates pial arteries by KATP and Kca channel activation. Brain Res. 1999; 816: 158-64.
12. Kim YH, Park JH, Hong SH, Koh JY. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science. 1999; 284: 647-50.
13. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor mediated signaling. Nat Med. 2001; 7: 59-64.
14. Wang YF, Tsirka SE, Strickland S, Stiege PE, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998; 4: 228-31.
15. Murciano JC, Medinilla S, Eslin D, Atochina E, Cines DB, Muzykantov VR. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nat Biotechnol. 2003; 21: 891-6.
16. Ganguly K, Krasik T, Medinilla S, Bdeir K, Cines D, Muzykantov VR, et al. Blood clearance and activity of erythrocyte-coupled fibrinolytics. J Pharmacol Exp Ther. 2005; 312: 1106-13.
17. Zaitsev S, Danielyan K, Murciano JC, Krasik T, Taylor RP, Pincus S, et al. Muzykantov VR. CR-1-directed targeting of tPA to circulating erythrocytes for prophylactic fibrinolysis. Blood. 2006; 108: 1895-902.
18. Danielyan K, Ganguly K, Ding B, Atochin D, Zaitsev S, Murciano JC, et al. Cerebrovascular thromboprophylaxis by erythrocyte coupled tPA. Circulation. 2008; 118: 1442-9.
19. Stein SC, Ganguly K, Belfeld CM, Xu X, Swanson WE, Chen XH, et al. Erthrocyte bound tissue plasminogen activator (tPA) is neuroprotective in experimental traumatic brain injury. J Neurotrauma. 2009; 26: 1585-92.
20. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci. 1999; 96: 12866-9.
21. Hayashi T, Sakai K, Sasaki C, Zhang WR, Warita H, Abe K. c-JUN N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett. 2000; 284: 195-9.
22. Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab. 2001; 21: 887-906.
23. Kuluz JW, Prado R, He D, Zhao W, Dietrich WD, Watson B. New pediatric model of ischemic stroke in infant piglets by photothrombosis. Stroke. 2007; 38: 1932-7.
24. Armstead WM, Ganguly K, Kiessling JW, Chen XH, Smith DH, Higazi AAR, et al. RBC-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia/ischemia through inhibition of ERK MAPK. J Cereb Blood Flow Metab. 2009; 29: 1463-74.
25. Armstead WM, Riley J, Cines DB, Higazi AAR. tPA contributes to impairment of ATP and calcium sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK. Brain Res. 2011; 1376: 88-93.
26. Armstead WM, Cines DB, Bdeir K, Bdeir Y, Stein SC, Higazi AAR. uPA modulates the age dependent effect of brain injury on cerebral hemodynamics through LRP and ERK MAPK. J Cereb Blood Flow Metab. 2009; 29: 524-33.
27. Armstead WM, Kiessling JW, Riley J, Cines DB, Higazi AAR. tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK. Neurol Res. 2011; 33: 726-33.
28. Armstead WM, Cines DB, Bdeir K, Kulikovskaya I, Stein SC, Higazi AAR. uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK. Brain Res. 2008; 1231: 121-31.
29. Dobbing J. The later growth of the brain and its vulnerability. Pediatrics. 1974; 53: 2-6.
30. Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children. Data from the nationwide inpatient sample. Stroke. 2007; 38: 1850-4.
31. Murciano JC, Higazi AA, Cines DB, Muzykantov VR. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile. J Control Release. 2009; 139: 190-6.
32. Zaitsev S, Spitzer D, Murciano JC, Ding BS, Tliba S, Kowalska MA, et al. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis. J Pharmacol Exp Ther. 2010; 332: 1022-31.
33. Zaitsev S, Spitzer D, Murciano JC, Ding BS, Tliba S, Kowalska MA, et al. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood. 2010; 115: 5241-8.
34. Armstead WM, Ganguly K, Kiessling JW, Riley J, Chen XH, Smith DH, et al. Signaling, delivery, and age as emerging issues in the benefit/risk ratio outcome of tPA for treatment of CNS ischemic disorders. J Neurochem. 2010; 113(2): 303-12.